• Toshiyuki Harada, Yasushi Akiyama, Atsuyuki Kurashima, Hideaki Nagai, Kazunari Tsuyuguchi, Takashi Fujii, Syuichi Yano, Eriko Shigeto, Toshihiko Kuraoka, Akira Kajiki, Yoshihiro Kobashi, Fumio Kokubu, Atsuo Sato, Shiomi Yoshida, Tomotada Iwamoto, and Hajime Saito.
• Center for Respiratory Diseases, Hokkaido Social Insurance Hospital, Sapporo, Japan. t-harada@hok-shaho-hsp.jp
• J. Clin. Microbiol. 2012 Nov 1; 50 (11): 3556-61.

AbstractIn recent years, many novel nontuberculous mycobacterial species have been discovered through genetic analysis. Mycobacterium massiliense and M. bolletii have recently been identified as species separate from M. abscessus. However, little is known regarding their clinical and microbiological differences in Japan. We performed a molecular identification of stored M. abscessus clinical isolates for further identification. We compared clinical characteristics, radiological findings, microbiological findings, and treatment outcomes among patients with M. abscessus and M. massiliense lung diseases. An analysis of 102 previous isolates of M. abscessus identified 72 (71%) M. abscessus, 27 (26%) M. massiliense, and 3 (3%) M. bolletii isolates. Clinical and radiological findings were indistinguishable between the M. abscessus and M. massiliense groups. Forty-two (58%) patients with M. abscessus and 20 (74%) patients with M. massiliense infections received antimicrobial treatment. Both the M. abscessus and M. massiliense groups showed a high level of resistance to all antimicrobials, except for clarithromycin, kanamycin, and amikacin. However, resistance to clarithromycin was more frequently observed in the M. abscessus than in the M. massiliense group (16% and 4%, respectively; P = 0.145). Moreover, the level of resistance to imipenem was significantly lower in M. abscessus isolates than in M. massiliense isolates (19% and 48%, respectively; P = 0.007). The proportions of radiological improvement, sputum smear conversion to negativity, and negative culture conversion during the follow-up period were higher in patients with M. massiliense infections than in those with M. abscessus infections. Patients with M. massiliense infections responded more favorably to antimicrobial therapy than those with M. abscessus infections.

32 keywords...

hide…